According to a recent market intelligence report, the global gout therapeutics market was valued at US$ 1874 Mn in 2018. … Keep Reading
The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of Omontys Injection by Affymax, Inc., of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited, of Deerfield, Ill. The recall is due to reports of anaphylaxis, a serious and life-threatening allergic reaction. Omontys is used to treat anemia in adult dialysis patients. Until further notice, health care providers should stop using Omontys and return the product to Takeda Pharmaceuticals.…
[column]Two mutations central to the development of infantile myofibromatosis (IM) – a disorder characterized by multiple tumors involving
[column]Advances in genetic profiling have allowed doctors to match more of their cancer patients with treatments that will target their particular illnesses.